Galaxy Surfactants Announces Strategic Collaboration for Overseas Manufacturing Plant

Mumbai-based speciality care products maker Galaxy Surfactants announced on Wednesday (March 5) that it has entered into a strategic collaboration through its group companies with a global customer to provide Engineering, Procurement, and Construction (EPC) services for performance surfactants and speciality ingredients manufacturing plant at an overseas location.

Key Aspects of the Collaboration

According to a regulatory filing, the collaboration involves providing process design, procurement, engineering, construction, and commissioning of the customer’s manufacturing facility. The move is expected to enhance Galaxy Surfactants’ global presence and strengthen its foothold in the surfactants and speciality ingredients sector.

Expansion of Partnership Post-Commissioning

The company further stated that it is in advanced discussions to expand its partnership with the customer beyond the commissioning of the plant. This expansion is expected to open new avenues for collaboration and business growth.

Confidentiality on Financial Terms

While the financial terms of the agreement have not been disclosed due to confidentiality agreements, the company emphasised that this partnership marks a significant step in strengthening its global operations and strategic alliances.

With this move, Galaxy Surfactants aims to bolster its presence in international markets, further cementing its position as a leading supplier of performance surfactants and specialty ingredients.

Stock Performance 

On March 06, 2025, Galaxy Surfactants share price ended 6.60% higher at ₹2,393.20 at 9:59 AM (IST). Galaxy Surfactants’s share price reached a 52-week high of ₹3,366.30 on September 17, 2024, and a 52-week low of ₹2,085.00 on March 03, 2025. As per BSE, the total traded volume for the stock stood at 558 shares with a turnover of ₹13.06 lakhs.

At the current price, Galaxy Surfactants shares are trading at a price-to-earnings (P/E) ratio of 49.39x, based on its trailing 12-month earnings per share (EPS) of ₹48.46, and a price-to-book (P/B) ratio of 5.94, according to exchange data.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.